ACL/PCL Reconstruction Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Grafts and Fixation Devices

ACL/PCL Reconstruction Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Grafts and Fixation Devices

The ACL/PCL reconstruction market was valued at around $1.2 billion globally in 2022 and is projected to grow at a CAGR of 7.3% during the forecast period to surpass $1.9 billion. The full report suite on the ACL/PCL reconstruction market encompasses grafts and fixation devices.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Procedure Volumes
Company Profiles, Product Portfolios and SWOT for Top Competitors
COVID-19 Impact Analysis

PROCEDURE NUMBERS

In 2022, the majority of ACL/PCL reconstruction procedures were performed using autograft tissue, which is typically less expensive than allograft. However, using autograft requires an additional surgery to harvest and prepare the tissue, which increases the risk of complications at the donor site and potential morbidity.

GLOBAL ACL/PCL RECONSTRUCTION MARKET TRENDS

The knee injury market is primarily driven by the high incidence of knee-related injuries, particularly in professional sports. To stay up-to-date with the latest and clinically approved treatment options, sports medicine manufacturers collaborate with professional sports associations. This collaboration results in financial support for research and development activities, clinical trials and studies, as well as educational programs and fellowships.

GLOBAL ACL/PCL RECONSTRUCTION MARKET SHARE INSIGHTS

The global ACL/PCL market there are three dominant competitors: Arthrex, Smith & Nephew, and DePuy Synthes. Arthrex was the leader in the combined ACL/PCL reconstruction market in 2022, with a dominant presence in each region of the global market. The company's strong performance in the ACL/PCL fixation device market was due in part to its leading position in the interference screw segment, with products including the BioComposite™, PLA, metal, and PEEK screws.

GLOBAL ACL/PCL RECONSTRUCTION MARKET SEGMENTATION SUMMARY

Grafts Market
Fixation Device Market

RESEARCH SCOPE SUMMARY

Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.